
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
Key areas that health systems should consider when adopting biosimilars
Date
July 12, 2022
By: McKesson RxO
Read time: 1 minute
Biosimilars are important to health system customers because of their ability to help manage chronic conditions at lower costs to patient and providers, but there are many key areas that health systems should consider when adopting biosimilars.
Download this informative Q & A to learn more about potential challenges, cost benefits, and how health systems can prepare for the future when it comes to biosimilars.
Learn how the McKesson RxO Utilization Analytics tool can help health system customers with their biosimilar utilization.
This visual helps illustrate the nuances of each type of bagging in specialty pharmacy and what it may mean for your health system.
As strategic partners, our Specialty Pharmacy Enablement experts can help drive improvements across the board.
Industry event highlights how connection, creativity, and a fresh perspective are shaping the future of health system innovation.
An exclusive introduction to our newest services and solutions designed to help forward-thinking health systems modernize their specialty and infusion strategies.
As the infusion services market continues to evolve and challenge one of health systems’ longstanding service lines – new opportunities are also emerging.
Drug shortages have decreased, but supply chain complexity requires ongoing innovation and resilience to maintain drug availability.
Integrated health system specialty pharmacies improve medication access, enhance treatment plan adherence, and support better outcomes.